Aldo Maggioni to Time Factors
This is a "connection" page, showing publications Aldo Maggioni has written about Time Factors.
Connection Strength
0.258
-
Patterns of treatment with antiplatelet therapy after an acute coronary syndrome: Data from a large database in a community setting. Eur J Prev Cardiol. 2019 05; 26(8):836-846.
Score: 0.036
-
Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019 10; 140(14):1156-1169.
Score: 0.010
-
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin. Gastroenterology. 2019 09; 157(3):682-691.e2.
Score: 0.009
-
Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis. Europace. 2019 Apr 01; 21(4):645-654.
Score: 0.009
-
Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study. Europace. 2019 Feb 01; 21(2):230-238.
Score: 0.009
-
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology. Cardiovasc Drugs Ther. 2019 02; 33(1):77-86.
Score: 0.009
-
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry. Int J Cardiol. 2018 Nov 15; 271:68-74.
Score: 0.009
-
Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report. Eur Heart J Cardiovasc Pharmacother. 2018 07 01; 4(3):172-179.
Score: 0.009
-
Improving Postdischarge Outcomes in Acute Heart Failure. Am J Ther. 2018 Jul/Aug; 25(4):e475-e486.
Score: 0.009
-
[ANMCO/ANCE/ARCA/GICR-IACPR intersociety consensus document: long-term antiplatelet therapy in patients with coronary artery disease]. G Ital Cardiol (Rome). 2018 May; 19(5):263-331.
Score: 0.009
-
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial. Metabolism. 2018 06; 83:205-215.
Score: 0.009
-
Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. Atherosclerosis. 2018 04; 271:120-127.
Score: 0.009
-
Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry. J Cardiovasc Electrophysiol. 2018 04; 29(4):566-572.
Score: 0.009
-
The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up. Eur J Prev Cardiol. 2018 03; 25(4):377-387.
Score: 0.008
-
Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. 2018 Mar; 107(3):214-221.
Score: 0.008
-
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. Circulation. 2017 10 17; 136(16):1560-1562.
Score: 0.008
-
Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail. 2018 02; 20(2):281-291.
Score: 0.008
-
Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail. 2018 02; 20(2):332-341.
Score: 0.008
-
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail. 2018 01; 20(1):100-110.
Score: 0.008
-
Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018 02; 20(2):345-354.
Score: 0.008
-
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post-Hoc Analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) Trial. J Am Heart Assoc. 2017 Jul 05; 6(7).
Score: 0.008
-
Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study. Eur J Heart Fail. 2017 06; 19(6):782-791.
Score: 0.008
-
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators. J Am Coll Cardiol. 2017 May 30; 69(21):2606-2618.
Score: 0.008
-
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. J Am Heart Assoc. 2017 May 29; 6(6).
Score: 0.008
-
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017 12; 19(12):1574-1585.
Score: 0.008
-
Clinical and prognostic value of spot urinary creatinine in chronic heart failure-An analysis from GISSI-HF. Am Heart J. 2017 Jun; 188:189-195.
Score: 0.008
-
Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry. Diabetes Care. 2017 05; 40(5):671-678.
Score: 0.008